Inclusion Criteria : 
  -  The diagnosis of pseudoachondroplasia is based on clinical assessment either in person or by photographic review by skeletal dysplasia specialist ( JTH )  , 
  -  Healthy beyond pseudoachondroplasia associated complications , 
Exclusion Criteria : 
  -  Current use of resveratrol
  -  Current use of blood thinners , lovastatin , ketoconazole , itraconazole , fexofenadine and triazolam . 
  -  Other non - pseudoachondroplasia related health conditions , e . g .  cancers . 
  -  Pregnancy or breastfeeding .  Women must use adequate contraception during the study . 
  -  Participation in another clinical study and / or using investigational agents . 
  -  Use of Non - steroid anti - inflammatory ( NSAIDs ) or aspirin . 
  -  Current use of Alfentanil , Cyclosporine , Dihydroergotamine , Dofetilide , Ergotamine , Fentanyl , Flibanserin , Oxycodone , Pimavanserin , Pimozide , Quinidine , Saquinavir , Sirolimus , Tacrolimus , Temsirolimus , Theophylline , Tizanidine , Thioridazine , Fosphenytoin , Phenytoin or Warfarin . 
  -  Baseline level of pain of  2 or higher on  10 point scale . 
  -  Platelet count below  50 , 000 per ul on baseline complete blood count ( CBC )  .